The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
| Summaries of Product Characteristics 1 - 30 of 222 |
|
|
|
Package
leaflet | Status for
supply | Name of the medicinal product |
|
|
|
European Medicines Agency's website:
FABHALTA - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Fabrazyme - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Fampridine Accord - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Fampridine Stada 10 mg depottabletti SPC 2023-04-28
|
|
|
|
European Medicines Agency's website:
Fampyra - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Famvir 125 mg, 250 mg, 500 mg tabletti, kalvopäällysteinen SPC 2024-01-31
|
|
|
|
European Medicines Agency's website:
Fareston - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Fareston 20 mg tabletti SPC 2024-07-29
|
|
PL
|
Resepti
|
Farlutal 500 mg tabletti SPC 2022-08-07
|
|
|
|
European Medicines Agency's website:
Farydak - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Fasenra - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Fasenra - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Faslodex - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Fasturtec - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Febuxostat Accord 120 mg tabletti, kalvopäällysteinen SPC 2023-02-17
|
|
PL
|
Resepti
|
Febuxostat Accord 80 mg tabletti, kalvopäällysteinen SPC 2023-02-17
|
|
|
|
European Medicines Agency's website:
Febuxostat Krka - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Febuxostat Viatris (ent. Febuxostat Mylan) - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Feiba 100 U-ml infuusiokuiva-aine ja liuotin, liuosta varten SPC 2024-03-25
|
|
PL
|
Resepti
|
Feiba 50 U-ml infuusiokuiva-aine ja liuotin, liuosta varten SPC 2024-01-26
|
|
PL
|
Resepti/itsehoito
|
Felden 0.5 prosenttinen geeli SPC 2024-03-07
|
|
PL
|
Resepti
|
Felodipin Hexal 2.5 mg depottabletti, SPC 2021-02-12
|
|
PL
|
Resepti
|
Felodipin Hexal 5 mg, 10 mg depottabletti SPC 2021-02-12
|
|
PL
|
Resepti
|
Felodipin ratiopharm 2.5 mg, 5 mg, 10 mg depottabletti SPC 2020-03-19
|
|
PL
|
Resepti
|
Felodipin SanoSwiss 5mg, 10mg depottabletti SPC 2022-10-06
|
|
PL
|
Resepti
|
Femar 2.5 mg tabletti, kalvopäällysteinen SPC 2024-05-02
|
|
PL
|
Itsehoito
|
Femke 30 mg tabletti, kalvopäällysteinen SPC 2022-10-27
|
|
PL
|
Resepti
|
Femoston 1-10 tabletti, kalvopäällysteinen SPC 2024-10-21
|
|
PL
|
Resepti
|
Femoston 2-10 tabletti, kalvopäällysteinen SPC 2024-10-21
|
|
PL
|
Resepti
|
Femoston conti 0.5-2.5 tabletti, kalvopäällysteinen SPC 2024-10-07
|
|
|
